News Features Reimbursement Issues Seem to Be Holding Renal Denervation Back Todd Neale December 19, 2024
News Conference News PCR London Valves 2024 Residual TR After Treating Mitral ViV Disease Linked to Worse Outcomes Michael O'Riordan November 26, 2024
News Conference News PCR London Valves 2024 Live Valve Cases Safe, With Outcomes Comparable to Trials and Practice Michael O'Riordan November 25, 2024
News Conference News TCT 2024 TRISCEND II: Full Results a Win for TTVR in Severe Tricuspid Regurgitation Michael O'Riordan October 30, 2024
News Conference News TCT 2024 TRILUMINATE: More Patient Data Reassure on TEER’s Benefits for Severe TR Michael O'Riordan October 29, 2024
News Opinion Editor's Corner TCT 2024 What’s Going to Be Big at TCT 2024? Michael O'Riordan October 17, 2024
News Features Initial US Commercial TriClip Cases Offer Hope, but Reimbursement Still a Big Question L.A. McKeown August 09, 2024
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for June 2024 Shelley Wood July 02, 2024
Presentation NY Valves 2024 Post-Market Considerations: How Can We Ensure Rational Diffusion of TTVI, Optimal Training and Maintenance of Quality? Presenter: Susheel K. Kodali June 06, 2024
Presentation NY Valves 2024 Lessons From the Initial FDA Trials Presenter: David J. Cohen June 06, 2024
News Conference News ACC 2024 Another Win for TAVI in Patients at Low-to-Intermediate Risk: DEDICATE-DZHK6 Yael L. Maxwell April 08, 2024
News Opinion Off Script Evoque and Patisiran: A Tale of Two Regulatory Journeys Sanjay Kaul, MD March 29, 2024
News Daily News First-Ever Performance, Quality Metrics Created for Valvular and Structural Disease Michael O'Riordan March 20, 2024
News Conference News THT 2024 Debating the Role of T-TEER in the Sickest Patients Michael O'Riordan March 05, 2024
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for February 2024 Shelley Wood March 01, 2024
News Daily News Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective Michael O'Riordan February 23, 2024
News Daily News FDA Advisors Set to Take on TriClip for TR as TRILUMINATE Questions Loom Michael O'Riordan February 09, 2024